STOCK TITAN

Argentum 47 Stock Price, News & Analysis

ARGQ OTC

Company Description

Argentum 47 Inc. (OTC PINK: ARGQ) is a diversified holding company operating in the Technology, Web Based Services, and Marketing Solutions sectors. With a focus on AI-powered digital marketing solutions, the company offers services such as branding, advertising, and lead generation. Recent developments include strategic expansion into the European medical cannabis market and the development of proprietary AI Technology into a Software-as-a-Service (SaaS) model. The company's commitment to innovation and growth is evident in its comprehensive medical cannabis project in Portugal and its revolutionary business energy claims initiative in the UK.

Stock Performance

$0.0073
0.00%
0.00
Last updated: April 27, 2025 at 09:30
- %
Performance 1 year
$1.8M
Market Cap
210.3M
Shares outstanding

SEC Filings

No SEC filings available for Argentum 47.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Diluted EPS (TTM)
Operating Cash Flow
Net Profit Margin
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Argentum 47 (ARGQ)?

The current stock price of Argentum 47 (ARGQ) is $0.0073 as of April 25, 2025.

What is the market cap of Argentum 47 (ARGQ)?

The market cap of Argentum 47 (ARGQ) is approximately 1.8M.

What sectors is Argentum 47 Inc. involved in?

Argentum 47 Inc. operates in the Technology, Web Based Services, and Marketing Solutions sectors.

What services does Argentum 47 Inc. offer?

Argentum 47 Inc. provides AI-powered digital marketing solutions, including branding, advertising, and lead generation.

What are some recent developments at Argentum 47 Inc.?

Recent developments include expansion into the European medical cannabis market, the development of proprietary AI Technology into a SaaS model, and the initiation of a business energy claims initiative in the UK.

Where is Argentum 47 Inc.'s comprehensive medical cannabis project located?

Argentum 47 Inc.'s comprehensive medical cannabis project is located near Lisbon, Portugal, and spans 4.3 hectares with further development planned in three phases.

What is the goal of Argentum 47 Inc.'s revolutionary business energy claims initiative in the UK?

The initiative aims to help businesses in the UK recover losses from unfair energy practices by leveraging AI-driven marketing tools to identify potential victims and facilitate compensation.